# PAX1

## Overview
PAX1 is a gene that encodes the paired box 1 protein, a transcription factor belonging to the PAX gene family, which is characterized by the presence of a conserved paired box domain. This protein plays a pivotal role in embryonic development, particularly in the formation of the thymus and axial skeleton. The paired box 1 protein is involved in regulating gene expression by binding to specific DNA sequences, thereby influencing the development of tissues derived from the pharyngeal pouches, such as the thymus and parathyroid glands (Yamazaki2020PAX1; Wu2022An). Mutations in the PAX1 gene have been associated with various congenital disorders, including otofaciocervical syndrome type 2 and severe combined immunodeficiency, as well as certain cancers, highlighting its clinical significance (Yamazaki2020PAX1; Thompson2020Overview).

## Structure
The PAX1 gene encodes a transcription factor that is part of the paired box-containing (PAX) gene family, which is highly conserved across species. The PAX1 protein contains a 128-amino acid paired-box domain (PD) responsible for DNA-binding and an 8-amino acid octapeptide domain (OP), both of which are involved in protein-protein interactions (Wu2022An). The paired domain has a bipartite structure, with both amino-terminal and carboxy-terminal regions contributing to DNA binding (Czerny1993DNA). This domain is crucial for interactions with other proteins, such as SOX10 in PAX3, while the OP is necessary for interactions between PAX5 and GRG4 (Wu2022An).

The molecular structure of PAX1, including its PD and OP domains, plays a significant role in its function during embryonic development and its association with diseases. Mutations in PAX1 can lead to congenital defects and have been linked to various cancers, highlighting the importance of its molecular structure in its biological roles (Wu2022An). The paired domain's bipartite structure allows it to bind to DNA from one side of the helix, interacting with two successive major grooves (Czerny1993DNA). However, specific details on the tertiary and quaternary structures of PAX1 are not provided in the available context.

## Function
PAX1 is a transcription factor that plays a critical role in the development and function of the human thymus and skeletal system. It is involved in the regulation of gene expression by binding to DNA, particularly influencing the development of tissues derived from the pharyngeal pouches, such as the thymus, tonsils, parathyroid glands, and thyroid (Yamazaki2020PAX1; Wu2022An). In the thymus, PAX1 is essential for thymic epithelial cell progenitors, which are crucial for a functional immune system. It affects the expression of genes involved in thymus development, such as FOXN1 and BMP4, and is necessary for proper thymus morphogenesis and maintenance (Yamazaki2020PAX1).

PAX1 is also involved in the development of the axial skeleton, including the vertebral column and limb buds. It regulates the specification, proliferation, migration, and differentiation of sclerotome cells, which are essential for skeletal patterning (Lang2007PAX; Wu2022An). The protein is active in the nucleus, where it influences transcriptional activity, as demonstrated by its role in regulating the Nkx3-2 promoter (Yamazaki2020PAX1).

## Clinical Significance
Mutations in the PAX1 gene are associated with several congenital conditions and diseases. Otofaciocervical syndrome type 2 (OTFCS2) is linked to homozygous PAX1 mutations, characterized by facial dysmorphism, ear anomalies, skeletal abnormalities, and severe T cell immunodeficiency (Yamazaki2020PAX1; Shaw2024The). These mutations often affect the paired-box domain, reducing DNA-binding capacity and transcriptional activity, which is crucial for thymic epithelial development (Yamazaki2020PAX1).

PAX1 mutations are also implicated in severe combined immunodeficiency (SCID), where thymic abnormalities lead to severe T cell lymphopenia and increased infection susceptibility (Yamazaki2020PAX1). In skeletal development, PAX1 mutations can result in congenital vertebral malformations, Klippel-Feil syndrome, and Jarcho-Levin syndrome, often presenting with vertebral malformations and facial dysmorphism (Wu2022An).

Alterations in PAX1 expression are linked to cancer biology, particularly in esophageal squamous cell carcinoma, where its promoter is hypermethylated, suggesting a tumor suppressor role (Thompson2020Overview). In colorectal cancer, PAX1 hypermethylation is a potential biomarker, indicating its role in tumor suppression (Huang2017DNA).

## Interactions
PAX1 is a transcription factor that plays a significant role in embryonic development and tissue differentiation. It contains a paired-box domain responsible for DNA binding, which is crucial for its function as a transcription factor. PAX1 interacts with DNA to regulate the transcription of target genes, influencing various developmental pathways (Wu2022An).

PAX1 has been shown to interact with the platelet-derived growth factor receptor-α (PDGFRα) gene, acting as a transcriptional activator. This interaction is particularly relevant in the context of neural tube defects, where mutant PAX1 proteins associated with spina bifida exhibit altered transcriptional activities, leading to a gain-of-function phenomenon that enhances PDGFRα-promoter activity in certain cell lines (Joosten1998Altered).

In addition to its interactions with DNA, PAX1 is involved in complex regulatory networks with other signaling molecules. For instance, it interacts with signaling pathways involving Shh and Noggin, which are important for the specification, proliferation, migration, and differentiation of sclerotome cells during skeletal development (Wu2022An). These interactions highlight the multifaceted role of PAX1 in developmental processes and its potential impact on congenital conditions when mutated.


## References


[1. (Czerny1993DNA) T Czerny, G Schaffner, and M Busslinger. Dna sequence recognition by pax proteins: bipartite structure of the paired domain and its binding site. Genes &amp; Development, 7(10):2048–2061, October 1993. URL: http://dx.doi.org/10.1101/gad.7.10.2048, doi:10.1101/gad.7.10.2048. This article has 292 citations.](https://doi.org/10.1101/gad.7.10.2048)

[2. (Shaw2024The) Taryn Shaw, Frederic G. Barr, and Aykut Üren. The pax genes: roles in development, cancer, and other diseases. Cancers, 16(5):1022, February 2024. URL: http://dx.doi.org/10.3390/cancers16051022, doi:10.3390/cancers16051022. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cancers16051022)

[3. (Yamazaki2020PAX1) Yasuhiro Yamazaki, Raul Urrutia, Luis M. Franco, Silvia Giliani, Kejian Zhang, Anas M. Alazami, A. Kerry Dobbs, Stefania Masneri, Avni Joshi, Francisco Otaizo-Carrasquero, Timothy G. Myers, Sundar Ganesan, Maria Pia Bondioni, Mai Lan Ho, Catherine Marks, Huda Alajlan, Reem W. Mohammed, Fanggeng Zou, C. Alexander Valencia, Alexandra H. Filipovich, Fabio Facchetti, Bertrand Boisson, Chiara Azzari, Bander K. Al-Saud, Hamoud Al-Mousa, Jean Laurent Casanova, Roshini S. Abraham, and Luigi D. Notarangelo. Pax1 is essential for development and function of the human thymus. Science Immunology, February 2020. URL: http://dx.doi.org/10.1126/sciimmunol.aax1036, doi:10.1126/sciimmunol.aax1036. This article has 62 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/sciimmunol.aax1036)

[4. (Lang2007PAX) Deborah Lang, Sara K. Powell, Rebecca S. Plummer, Kacey P. Young, and Bruce A. Ruggeri. Pax genes: roles in development, pathophysiology, and cancer. Biochemical Pharmacology, 73(1):1–14, January 2007. URL: http://dx.doi.org/10.1016/j.bcp.2006.06.024, doi:10.1016/j.bcp.2006.06.024. This article has 221 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.bcp.2006.06.024)

[5. (Wu2022An) Weiyin Wu, Xiangjun Kong, Yanhan Jia, Yihui Jia, Weimei Ou, Cuilian Dai, Gang Li, and Rui Gao. An overview of pax1: expression, function and regulation in development and diseases. Frontiers in Cell and Developmental Biology, October 2022. URL: http://dx.doi.org/10.3389/fcell.2022.1051102, doi:10.3389/fcell.2022.1051102. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2022.1051102)

[6. (Huang2017DNA) Jin Huang, Zhi-Rong Tan, Jing Yu, He Li, Qiao-Li Lv, Ying-Ying Shao, and Hong-Hao Zhou. Dna hypermethylated status and gene expression of &lt;em&gt;pax1/sox1&lt;/em&gt; in patients with colorectal carcinoma. OncoTargets and Therapy, Volume 10:4739–4751, September 2017. URL: http://dx.doi.org/10.2147/OTT.S143389, doi:10.2147/ott.s143389. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.2147/OTT.S143389)

[7. (Thompson2020Overview) Brian Thompson, Emily A. Davidson, Wei Liu, Daniel W. Nebert, Elspeth A. Bruford, Hongyu Zhao, Emmanouil T. Dermitzakis, David C. Thompson, and Vasilis Vasiliou. Overview of pax gene family: analysis of human tissue-specific variant expression and involvement in human disease. Human Genetics, 140(3):381–400, July 2020. URL: http://dx.doi.org/10.1007/s00439-020-02212-9, doi:10.1007/s00439-020-02212-9. This article has 37 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-020-02212-9)

[8. (Joosten1998Altered) Paul H. L. J. Joosten, Frans A. Hol, Sylvia E. C. van Beersum, Heiko Peters, Ben C. J. Hamel, Gijs B. Afink, Everardus J. J. van Zoelen, and Edwin C. M. Mariman. Altered regulation of platelet-derived growth factor receptor-α gene-transcription in vitro by spina bifida-associated mutant pax1 proteins. Proceedings of the National Academy of Sciences, 95(24):14459–14463, November 1998. URL: http://dx.doi.org/10.1073/pnas.95.24.14459, doi:10.1073/pnas.95.24.14459. This article has 21 citations.](https://doi.org/10.1073/pnas.95.24.14459)